Systematic review of the global epidemiology of viral-induced acute liver failure
Open Access
- 20 July 2020
- Vol. 10 (7), e037473
- https://doi.org/10.1136/bmjopen-2020-037473
Abstract
Objectives The aetiology and burden of viral-induced acute liver failure remains unclear globally. It is important to understand the epidemiology of viral-induced ALF to plan for clinical case management and case prevention. Participants This systematic review was conducted to synthesize data on the relative contribution of different viruses to the aetiology of viral-induced acute liver failure in an attempt to compile evidence that is currently missing in the field. EBSCOhost, PubMed, ScienceDirect, Scopus and Web of Science were searched for relevant literature published from 2009 to 2019. The initial search was run on 9 April 2019 and updated via PubMed on 30 September 2019 with no new eligible studies to include. Twenty-five eligible studies were included in the results of this review. Results This systematic review estimated the burden of acute liver failure after infection with hepatitis B virus, hepatitis A virus, hepatitis C virus, hepatitis E virus, herpes simplex virus/human herpesvirus, cytomegalovirus, Epstein-Barr virus and parvovirus B19. Data were largely missing for acute liver failure after infection with varicella-zostervirus, human parainfluenza viruses, yellow fever virus, coxsackievirus and/or adenovirus. The prevalence of hepatitis A-induced acute liver failur was markedly lower in countries with routine hepatitis A immunisation versus no routine hepatitis A immunisation. Hepatitis E virus was the most common aetiological cause of viral-induced acute liver failure reported in this review. In addition, viral-induced acute liver failure had poor outcomes as indicated by high fatality rates, which appear to increase with poor economic status of the studied countries. Conclusions Immunisation against hepatitis A and hepatitis B should be prioritised in low-income and middle-income countries to prevent high viral-induced acute liver failure mortality rates, especially in settings where resources for managing acute liver failure are lacking. The expanded use of hepatitis E immunisation should be explored as hepatitis E virus was the most common cause of acute liver failure. Registration PROSPERO registration number: CRD42017079730.Keywords
This publication has 38 references indexed in Scilit:
- Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreementJournal of Clinical Epidemiology, 2012
- Systematic review: acute liver failure – one disease, more than 40 definitionsAlimentary Pharmacology & Therapeutics, 2012
- Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011Hepatology, 2012
- Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination programHepatic Medicine: Evidence and Research, 2011
- Acute liver failureThe Lancet, 2010
- Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantationHepatology International, 2009
- Natural course of fulminant hepatic failure: The scenario in Bangladesh and the differences from the westSaudi Journal of Gastroenterology, 2009
- Acute liver failureHeart, 2005
- Approaches to acute liver failure in childrenPediatric Transplantation, 2004
- Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failureJournal of Gastroenterology and Hepatology, 1999